Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Advertisement
GAM ID: header
Article
Page 73
Posts about this type
JCP
Article
Introduction: Remission of Anxiety-Related Disorders
October 1, 2001
Richard C. Shelton
PCC
Article
Mechanisms of Action in the Treatment of Anxiety
October 1, 2001
Richard C. Shelton
,
Laurel L. Brown
PCC
Article
Serotonergic and Noradrenergic Reuptake Inhibitors: Prediction of Clinical Effects From In Vitro Potencies
October 1, 2001
Alan Frazer
PCC
Article
Treatment of Anxiety Disorders to Remission
October 1, 2001
James C. Ballenger
JCP
Article
Comorbidity, Neurobiology, and Pharmacotherapy of Social Anxiety Disorder
October 1, 2001
Mark H. Pollack
JCP
Article
Contemporary Management of Comorbid Anxiety and Depression in Geriatric Patients
October 1, 2001
P. Murali Doraiswamy
JCP
Article
Mechanisms of Action in the Treatment of Anxiety
October 1, 2001
Richard C. Shelton
,
Laurel L. Brown
JCP
Article
Serotonergic and Noradrenergic Reuptake Inhibitors: Prediction of Clinical Effects From In Vitro Potencies
October 1, 2001
Alan Frazer
JCP
Article
Treatment of Anxiety Disorders to Remission
October 1, 2001
James C. Ballenger
JCP
Article
Comorbidity in Generalized Anxiety Disorder: Impact and Implications
September 1, 2001
Dan J. Stein
JCP
Article
Consensus Statement on Generalized Anxiety Disorder From the International Consensus Group on Depression and Anxiety
September 1, 2001
James C. Ballenger
,
Jonathan R. T. Davidson
,
Yves Lecrubier
, et al
JCP
Article
Generalized Anxiety Disorder: Nature and Course
September 1, 2001
Hans-Ulrich Wittchen
,
Jurgen Hoyer
JCP
Article
Introduction: Focus on Generalized Anxiety Disorder
September 1, 2001
James C. Ballenger
JCP
Article
What Is Generalized Anxiety Disorder?
September 1, 2001
Karl Rickels
,
Moira A. Rynn
JCP
Article
Neurobiological Mechanisms in Generalized Anxiety Disorder
September 1, 2001
David J. Nutt
JCP
Article
Pharmacotherapy for Generalized Anxiety
September 1, 2001
Learn about the Pharmacotherapy of Generalized Anxiety Disorder, including treatments, alternatives, and side effects.
Jonathan R. T. Davidson
JCP
Article
Psychotherapy for Generalized Anxiety Disorder
September 1, 2001
Thomas D. Borkovec
,
Ayelet M. Ruscio
JCP
Article
Clinical Trial Design Issues in Schizophrenic Research
August 1, 2001
Daniel E. Casey
JCP
Article
Dose Selection and Comparator Drugs in Schizophrenia Research
August 1, 2001
John M. Kane
JCP
Article
Evaluating Characteristics of Patient Selection and Dropout Rates
August 1, 2001
Samuel J. Keith
JCP
Article
Evaluating Clinical Trial Data: Outcome Measures
August 1, 2001
Robert R. Conley
JCP
Article
Hypothesis and Hypothesis Testing in the Clinical Trial
August 1, 2001
Jeffrey A. Lieberman
JCP
Article
Interpretations and Conclusions in the Clinical Trial
August 1, 2001
John P. Docherty
JCP
Article
Introduction: Evaluating Clinical Trial Data From Schizophrenia Research
August 1, 2001
Carol A. Tamminga
«
1
…
71
72
73
74
75
…
107
»
